Abstract
Purpose
Knee osteoarthritis (OA) is one of the most common musculoskeletal diseases. Opioids have been increasingly used in the treatment of severe knee OA-related pain, particularly in the USA. Less is known about the patterns of use of opioids among Danish patients with severe knee OA. We investigated opioid use among Danish patients with severe knee OA in the 5 years preceding knee replacement surgery (KR).
Methods
We identified adults who had undergone KR from January 1st, 2005, to December 31st, 2018, using the Danish National Patient Register. These patients were considered to have severe knee OA in the 5-year period leading up to KR. Individual-level data on prescribed opioids were retrieved from the Danish National Prescription Registry.
Results
We identified 77,168 severe knee OA patients (mean age 66 years). The prevalence of opioid users increased from 21% 5 years before KR to 40% 1 year before. Total use of opioids increased each year and doubled from 3254 mg oral morphine equivalents (OMEQ)/1000 individuals/day 5 years before to 6396 mg OMEQ/1000 individuals/day the year before KR corresponding to an increase of 3141 mg OMEQ (95% confidence interval 3010 to 3273). Tramadol was the most frequently used opioid. About 10% of the population accounted for 90% of the total opioid use.
Conclusion
Among patients with severe knee OA, the prevalence and total use of opioids doubled during the 5 years before KR. In addition, 10% of the study population was responsible for 90% of the opioids used.
Similar content being viewed by others
References
Sundhedsstyrelsen (2012) Knæartrose - nationale kliniske retningslinjer og faglige visitationsretningslinjer
Kraus VB, Blanco FJ, Englund M, Karsdal MA, Lohmander LS (2015) Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis Cartilage 23(8):1233–1241
Sundhedsstyrelsen (2015) Sygdomsbyrden i Danmark - sygdomme
da Costa BR, Nüesch E, Kasteler R, Husni E, Welch V, Rutjes AW, Jüni P (2014) Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane library. (9):CD003115-CD
Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA et al (2019) OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 27(11):1578–1589
Shadbolt C, Schilling C, Inacio MC, Abbott JH, Pryymachenko Y, Wilson R et al (2020) Opioid use and total joint replacement. Curr Rheumatol Rep 22(10)
Ekholm O, Kurita GP, Højsted J, Juel K, Sjøgren P (2014) Chronic pain, opioid prescriptions, and mortality in Denmark: Aa population-based cohort study. Pain (Amsterdam) 155(12):2486–2490
Dowell D, Haegerich TM, Chou R (2016) CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA, J Am Med Assoc 315(15):1624–1645
Bell KL, Shohat N, Goswami K, Tan TL, Kalbian I, Parvizi J (2018) Preoperative opioids increase the risk of periprosthetic joint infection after total joint arthroplasty. J Arthroplasty 33(10):3246–51.e1
Ben-Ari A, Chansky H, Rozet I (2017) Preoperative opioid use is associated with early revision after total knee arthroplasty a study of male patients treated in the veterans affairs system. Journal of Bone and Joint Surgery - American Volume 99(1):1–9
Goplen CM, Verbeek W, Kang SH, Jones CA, Voaklander DC, Churchill TA et al (2019) Preoperative opioid use is associated with worse patient outcomes after Total joint arthroplasty: a systematic review and meta-analysis. BMC Musculoskelet Disord 20(1):234
Sundhedsministeriet. Spørgsmål til sundhedminsteren. Available from: https://www.ft.dk/samling/20181/almdel/suu/spm/225/svar/1549655/2004344.pdf . Accessed 6 April 2021
Nissen SK, Pottegård A, Ryg J (2019) Trends of opioid utilisation in Denmark: a nationwide study. Drugs - Real World Outcomes 6(4):155–164
Sundhedsstyrelsen (2016) Kortlægning af opioidforbruget i Danmark: med fokus på patienter med kroniske non-maligne smerter.
Sørensen AMS, Rasmussen L, Ernst MT, Mogensen SH, Laursen MV, Jimenez-Solem E et al (2021) Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study. Eur J Clin Pharmacol 77(4):617–624
Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT (2015) The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449–490
World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems (ICD). Available from: https://icd.who.int/browse10/2019/en. Accessed 9 Mar 2021
Nordic Centre for Classifications in Health Care. The Nordic Medico-Statistical Committee (NOMESCO) Classification of Surgical Procedures. Available from: http://norden.diva-portal.org/smash/get/diva2:968721/FULLTEXT01.pdf. Accessed March 9, 2021.
Jürgensen HJ, Frølund C, Gustafsen J, Mosbech H, Guldhammer B, Mosbech J (1986) Registration of diagnoses in the Danish National Registry of Patients. Methods Inf Med 25(3):158–164
Lass P, Lilholt J, Thomsen L, Lundbye-Christensen S, Enevoldsen H, Simonsen OH (2006) The quality of diagnosis and procedure coding in Orthopaedic surgery Northern Jutland. Ugeskrift for læger 168(48):4212–4215
Kildemoes HW, Sørensen HT, Hallas J (2011) The Danish National Prescription Registry. Scand J Public Health 39(7 Suppl):38–41
WHO Collaborating Centre for Drug Statistics Methodology (2020) Guidelines for ATC classification and DDD assignment 2021 Oslo, Norway
Nielsen S, Degenhardt L, Hoban B, Gisev N (2016) A synthesis of oral morphine equivalents (OME) for opioid utilisation studies. Pharmacoepidemiol Drug Saf 25(6):733–737
Jarlbaek L, Andersen M, Hallas J, Engholm G, Kragstrup J (2005) Use of opioids in a Danish population-based cohort of cancer patients. J Pain Symptom Manage 29(4):336–343
Svendsen K, Borchgrevink PC, Fredheim O, Hamunen K, Mellbye A, Dale O (2011) Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliat Med 25(7):725–732
Svendsen K, Skurtveit S, Romundstad P, Borchgrevink PC, Fredheim OMS (2012) Differential patterns of opioid use: defining persistent opioid use in a prescription database: differential patterns of persistent opioid use. Eur J Pain 16(3):359–369
National Comitee on Health Research Ethics (2019) What to notify? Dated the 19. February 2019. Available from: https://en.nvk.dk/how-to-notify/what-to-notify. Accessed 5 Mar 2021
Thygesen LC, Daasnes C, Thaulow I, Brønnum-Hansen H (2011) Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 39(7 Suppl):12–16
Jin Y, Solomon DH, Franklin PD, Lee YC, Lii J, Katz JN et al (2019) Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees. Osteoarthritis Cartilage 27(10):1445–1453
Inacio MCS, Cashman K, Pratt NL, Gillam MH, Caughey G, Graves SE et al (2018) Prevalence and changes in analgesic medication utilisation 1 year prior to total joint replacement in an older cohort of patients. Osteoarthritis Cartilage 26(3):356–362
Wilson R, Pryymachenko Y, Audas R, Abbott JH (2019) Long-term opioid medication use before and after joint replacement surgery in New Zealand. N Z Med J 132(1507):33–47
Rajamäki TJ Jr, Puolakka PA, Hietaharju A, Moilanen T, Jämsen E (2019) Use of prescription analgesic drugs before and after hip or knee replacement in patients with osteoarthritis. BMC Musculoskelet Disord 20(1):427
Sundhedsstyrelsen (2010) Det danske sundhedsvæsen i internationalt perspektiv
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartil 16(2):137–62
McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM et al (2014) OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 22(3):363–388
Avouac JMD, Gossec LMD, Dougados MMD (2007) Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 15(8):957–965
Kristensen N, Nymann C, Konradsen H (2016) Implementing research results in clinical practice- the experiences of healthcare professionals. BMC Health Serv Res 16:48
Lynge E, Sandegaard JL, Rebolj M (2011) The Danish National Patient Register. Scand J Public Health 39(7 Suppl):30–33
Rennick A, Atkinson T, Cimino NM, Strassels SA, McPherson ML, Fudin J (2016) Variability in opioid equivalence calculations. Pain Med 17(5):892–898
Author information
Authors and Affiliations
Contributions
ML, JBT, and MSJ were involved in the design of the study. All authors provided input to the statistical analysis plan. ML performed the statistical analysis in collaboration with JBT and MSJ. ML wrote the first draft of the manuscript. All authors contributed to critically reviewing, editing, and revising the manuscript and approved the final version of the manuscript. JBT is the guarantor.
Corresponding author
Ethics declarations
Competing interests
JBT holds a research grant from Pfizer outside the submitted work. All other authors have no competing interests to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lundberg, M., Johansson, M.S., Søndergaard, J. et al. Opioid use among Danish patients with severe knee osteoarthritis: a drug utilization study. Eur J Clin Pharmacol 78, 1481–1486 (2022). https://doi.org/10.1007/s00228-022-03350-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-022-03350-x